Как дедушку поднял на ноги "Агарик" после неудачного лечения плазмоцитомы

[Вадим Асадулин]

Evid Based Complement Alternat Med. 2013; 2013: 842619.
Published online Oct 31, 2013. doi: 10.1155/2013/842619
PMCID: PMC3833359
The Medicinal Values of Culinary-Medicinal Royal Sun Mushroom (Agaricus blazei Murrill)
Hang Wang, Zhiming Fu, and Chunchao Han*
Author information ► Article notes ► Copyright and License information ►
Go to:
Abstract
Agaricus blazei Murrill (ABM), a mushroom native to Brazil, is a basidiomycete brown fungus, which is popularly known as “Cogumelo do Sol” in Brazil or “Himematsutake” in Japan, and there has been a prominent increase in the use of ABM for therapeutic and medicinal purposes. ABM is useful against a variety of diseases like cancer, tumor, chronic hepatitis, diabetes, atherosclerosis, hypercholesterolemia, and so on. In this review, we demonstrated various pharmacological effects of ABM, so that we can use different effects of ABM against different diseases and provide reference for the study of ABM in the future.
Conclusion
Agaricus blazei Murrill, a mushroom of biomedical importance, contains a number of bioactive components, many of them biological are response modifiers which activate our immune systems for a multitude of defensive functions (Figure 3). Polysaccharides of A. brasiliensis have been known to have anticancer, antiviral, and immunomodulatory effects, and other substances are probably involved as well. Moreover, β-glucans and their enzymatically hydrolyzed oligosaccharides (AO) from A. brasiliensis show antihyperglycemic, antihypertriglyceridemic, antihypercholesterolemic, and antiarteriosclerotic activities [25]. Therefore, the pharmacological effects and health function of A. brasiliensis are more and more focused on in the world. Although there seems to be clear evidences that ABM extract are rich in β-glucans, which presumably contribute to the observed pharmacological activities, isolation, and dose response studies, as well as chemical identification and quantification of specific compounds responsible for the potential benefit from ABM, mushroom ingestion should be fully developed. Careful clinical studies comparing the activity of the whole mushroom extracts, isolated compounds, and epidemiological data still need to determine whether A. brasiliensis provides real clinical benefits.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833359/
Вот один из последних научных обзоров за 2013 год исследований бразильского шампиньона из Китая, ни слова об излечении рака.
Кстати, под народным словом «рак» - сотни разных заболеваний и универсального средства найдено не будет.